Cypress Bioscience, Sanquin Blood Supply Foundation deal

CYPB and the CLB division of Sanquin, a manufacturer of blood derivatives, expanded their 1998 deal to improve yields of CYPB’s Cyplex platelet alternative (see BioCentury, Feb. 23, 1998). As expanded...